Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Circulating Tumor Modified HPV DNA-Guided Radiotherapy De-intensification of the Elective Neck (RaDEN) in Squamous Cell Carcinoma of the Head and Neck

NCT05962242 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT05962242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05962242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Circulating Tumor Modified HPV DNA-Guided Radiotherapy De-intensification of the Elective Neck (RaDEN) in Squamous Cell Carcinoma of the Head and Neck
Lead sponsor
University of Virginia
Phase
Phase 2
Overall status
Recruiting
Start date
June 28, 2024
Completion date
November 1, 2029
Enrollment
90 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

squamous cell carcinoma of the oropharynx